{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Cancer",
      "Galectin-3",
      "Inflammatory cytokines",
      "Ras/MAPK pathway",
      "Regulation mechanism",
      "Transcription factors"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26898438",
  "DateCompleted": {
    "Year": "2016",
    "Month": "12",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2016",
        "Month": "01",
        "Day": "29"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.biopha.2016.01.014",
      "S0753-3322(15)30179-7"
    ],
    "Journal": {
      "ISSN": "1950-6007",
      "JournalIssue": {
        "Volume": "78",
        "PubDate": {
          "Year": "2016",
          "Month": "Mar"
        }
      },
      "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
      "ISOAbbreviation": "Biomed Pharmacother"
    },
    "ArticleTitle": "Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression.",
    "Pagination": {
      "StartPage": "165",
      "EndPage": "171",
      "MedlinePgn": "165-171"
    },
    "Abstract": {
      "AbstractText": [
        "Galectin-3, a multifunctional protein, distributes inside and outside cells and plays an important role in tumor cell adhesion, proliferation, differentiation, angiogenesis, and metastasis in multiple tumors. Changes in galectin-3 expression are commonly seen in cancer and pre-cancerous conditions. Therefore, to understand the molecular regulation of galectin-3 expression could aid the development of new approach for cancer treatment. This review summarizes different expression of galectin-3 in cancer cells and patients' serum, the regulation mechanism and the potential therapeutic targets of galectin-3 in cancer progression."
      ],
      "CopyrightInformation": "Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, PR China."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Lei",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, PR China. Electronic address: guoxl@sdu.edu.cn."
          }
        ],
        "LastName": "Guo",
        "ForeName": "Xiu-Li",
        "Initials": "XL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Biomed Pharmacother",
    "NlmUniqueID": "8213295",
    "ISSNLinking": "0753-3322"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Galectin 3"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Galectin 3"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Biological"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Targeted Therapy"
    },
    {
      "QualifierName": [
        "blood",
        "metabolism",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    }
  ]
}